AMSURG CORP
8-A12G, 1999-12-03
HOSPITALS
Previous: AMSURG CORP, 8-K, 1999-12-03
Next: MEDISYS TECHNOLOGIES INC, 10QSB/A, 1999-12-03



<PAGE>   1
                                    FORM 8-A

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                    PURSUANT TO SECTION 12(b) OR 12(g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                                  AMSURG CORP.
- --------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)


Tennessee                                                    62-1493316
- --------------------------------------------------------------------------------
(State of incorporation or organization)                     (I.R.S. Employer
                                                             Identification No.)

              20 Burton Hills Boulevard, Nashville, Tennessee 37215
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)                    (Zip Code)

If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box.[ ]

If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box.[X]

Securities Act registration statement file number to which this form relates:

                                                                 ---------------
                                                                 (If applicable)

Securities to be registered pursuant to Section 12(b) of the Act:

                                                 Name of Each Exchange on Which
Title of Each Class to be Registered             Each Class is to be Registered
- ------------------------------------             ------------------------------

- ---------------------------------------      -----------------------------------

- ---------------------------------------      -----------------------------------

- ---------------------------------------      -----------------------------------

        Securities to be registered pursuant to Section 12(g) of the Act:
          Series C Junior Participating Preferred Stock Purchase Rights
- --------------------------------------------------------------------------------
                                (Title of class)




<PAGE>   2

Item 1. Description of Registrant's Securities to be Registered

         On November 19, 1999 we adopted a rights agreement (commonly known as a
"poison pill"). The discussion below describes the rights agreement but is not
complete, so you should read it together with the rights agreement. The rights
agreement is attached as an exhibit to a Current Report on Form 8-K we filed
with the Securities and Exchange Commission on December 3, 1999 and is
incorporated herein by reference.

ISSUANCE OF RIGHTS

         Under the rights agreement, we will issue the following stock purchase
rights:

         -        For each share of our Class A Common Stock, no par value per
                  share, outstanding on December 16, 1999 we will issue one
                  right; and

         -        For each share of our Class B Common Stock, no par value per
                  share, outstanding on December 16, 1999 we will issue one
                  right.

         In addition, one right will automatically attach to each share of
common stock that we issue between December 16, 1999 and the time that the
rights become exercisable. When exercised, each right will entitle its holder to
purchase from us one one-hundredth of a share (a "unit") of our Series C Junior
Participating Preferred Stock, no par value per share (the "Series C Preferred
Stock"), at an exercise price of $48.00 per unit, subject to adjustment.

INITIAL EXERCISE OF RIGHTS

         The rights initially will not be exercisable. Instead, the rights will
be attached to and trade with all shares of our common stock outstanding as of,
and issued after, December 16, 1999. The rights will separate from the common
stock and will become exercisable upon the earlier of the following events (the
"distribution date"):

         -        The close of business on the tenth business day (or later day
                  as our board of directors may determine) following the first
                  public announcement that a person or group of affiliated or
                  associated persons (other than certain "exempt persons") has
                  acquired beneficial ownership of 15% or more of our shares of
                  Class A Common Stock then outstanding or 15% or more of our
                  shares of Class B Common Stock then outstanding (an "Acquiring
                  Person"); or

         -        The close of business on the tenth business day (or some later
                  day as our board of directors may determine) following the
                  commencement of a tender offer or exchange offer that could
                  result in a person or group becoming the beneficial owner of
                  15% or more of our shares of Class A Common Stock then
                  outstanding or 15% or more of our shares of Class B Common
                  Stock then outstanding.


                                       2
<PAGE>   3

         The rights will expire at the close of business on December 2, 2009
unless we redeem or exchange the rights as described below.

         The exempt persons who are not considered Acquiring Persons include (1)
Wasatch Advisors, Inc. and (2) Waddell & Reed Investment Management Company,
Waddell & Reed, Inc., Waddell & Reed Financial, Inc., and Waddell & Reed
Financial Services, Inc. (collectively the "Waddell & Reed Companies") Should
Wasatch acquire an additional share of our Class A Common Stock after the date
of the rights agreement it will no longer be an exempt person provided that it
then falls within the definition of Acquiring Person. Should any of the Waddell
& Reed Companies acquire an additional share of our Class B Common Stock after
the date of the rights agreement each of the Waddell & Reed Companies will no
longer be an exempt person provided that it then falls within the definition of
Acquiring Person.

EVIDENCE OF RIGHTS

         Until the rights become exercisable:

         -        The rights will be evidenced by and transferred with our
                  common stock certificates; and

         -        New common stock certificates issued after December 16, 1999
                  will contain a notation incorporating the rights agreement by
                  reference; and

         -        Any surrender for transfer of any certificates for our common
                  stock will also constitute the transfer of the rights
                  associated with the common stock represented by those
                  certificates.

         As soon as practicable after the rights become exercisable, we will
mail out rights certificates to the holders of our common stock who are eligible
to receive rights. After we mail them out, the separate rights certificates
alone will represent the rights.

EXERCISE AFTER SOMEONE BECOMES AN ACQUIRING PERSON

         After public announcement that a person has become an Acquiring Person,
each holder of a right will have the right to receive upon exercise of the
rights that number of shares of Class A Common Stock (or in our board's
discretion, some other consideration), having a value of two times the then
current purchase price of the right. However, this will not apply to an
Acquiring Person or their associates or affiliates, whose rights will have
become null and void.

         Under certain circumstances, each holder of a right will have the right
to receive upon exercise of the rights common stock of the acquiring company
having a value equal to two times the then current purchase price of the right.
Each holder of a right will receive the right contemplated


                                       3
<PAGE>   4



by this paragraph in the event that, at any time on or after the date it is
publicly announced that a person has become an Acquiring Person:

         -        We consolidate with, or merge with and into, any other person,
                  and we are not the continuing or surviving corporation; or

         -        Any person consolidates with us, or merges with us and we are
                  the continuing or surviving corporation of that merger and, in
                  connection with that merger, all or part of the shares of our
                  common stock are changed into or exchanged for stock or other
                  securities of any other person or cash or any other property;
                  or

         -        We sell or transfer 50% or more of our assets or earning
                  power.

         The holder of a right will continue to have this right whether or not
that holder has previously exercised its right in accordance with the first
paragraph of this subsection. Rights that are or were beneficially owned by an
Acquiring Person may (under certain circumstances specified in the rights
agreement) become null and void.

EXCHANGE

         At any time after a person becomes an Acquiring Person, we may exchange
all or part of the outstanding and exercisable rights for shares of our Class A
Common Stock at an exchange ratio specified in the rights agreement. We
generally may not make an exchange after any person becomes the beneficial owner
of 50% or more of either our Class A Common Stock or Class B Common Stock.

ADJUSTMENT

         The purchase price and the number of shares of Class A Common Stock or
other securities or property issuable upon exercise of the rights is subject to
adjustment from time to time to prevent certain types of dilution. With certain
exceptions, the purchase price of the rights will not be adjusted until
cumulative adjustments amount to at least 1% of the purchase price. We are not
obligated to issue fractional units or shares of Class A Common Stock. If we
decide not to issue fractional units or shares of Class A Common Stock, we will
make an adjustment in cash based on the fair market value of a unit or share on
the last trading date prior to the date of exercise.

REDEMPTION

         We may redeem the rights in whole, but not in part, at a price of
$0.001 per right (payable in cash, preferred stock or other consideration that
we deem appropriate). However, we may only redeem the rights until the earlier
of ten days after someone becomes an Acquiring Person or December 2, 2009.


                                       4
<PAGE>   5



         Once redeemed, the rights will terminate immediately and the only right
of the holders of the rights will be to receive the redemption price.

AMENDMENT OF RIGHTS AGREEMENT

         We may amend the rights agreement without the approval of the holders
of our common stock until the distribution date. After the distribution date and
without the approval of the rights holders, we will only be able to amend the
rights agreement in order to cure any ambiguity, defect or inconsistency, to
shorten or lengthen any time period, or to make changes that do not adversely
affect the interests of rights holders excluding the interests of an Acquiring
Person or their associates or affiliates. We may only amend the time period
governing redemption of the rights if the rights are presently redeemable.

OTHER

         Until a right is exercised, the holder will have no rights as a
shareholder of ours as a result of the rights. This means, for example, that
until it is exercised, a right will not entitle its holder to vote or receive
dividends like one of our shareholders. The distribution of the rights will not
be taxable to shareholders or to us. However, shareholders may, depending upon
the circumstances, recognize taxable income in the event that the rights become
exercisable for units of Series C Preferred Stock, shares of Class A Common
Stock, other consideration or for common stock of an acquiring company.

         The discussion above describes the rights and the rights agreement but
is not complete, so you should read it together with the rights agreement. The
rights agreement is filed as an exhibit to a Current Report on Form 8-K we filed
with the SEC on December 3, 1999 and is incorporated herein by reference. We
have attached to the rights agreement as Exhibits A, B, and C respectively, the
form of rights certificate, the summary of rights and the form of articles of
amendment to our amended and restated charter.

         As of December 2, 1999, 9,746,983 shares of our Class A Common Stock
were issued and outstanding and 4,787,131 shares of our Class B Common Stock
were issued and outstanding. Each share of our common stock outstanding on
December 16, 1999 will receive one right. As long as the rights are attached to
our common stock, we will issue one right for each share of our common stock
issued between the December 16, 1999 and the distribution date. A total of
398,000 shares of Series C Preferred Stock have been reserved for issuance upon
exercise of the rights, subject to adjustment.

         The units of Series C Preferred Stock that may be acquired upon
exercise of the rights will be nonredeemable and subordinate to any other shares
of preferred stock that may be issued by the Company.

         Each unit of Series C Preferred Stock will be entitled to receive,
when, as and if declared, dividends at the same rate as dividends are paid with
respect to the Class A Common Stock.


                                       5
<PAGE>   6



         In the event of liquidation, the holder of a unit of Series C Preferred
Stock will be entitled to share in any assets remaining ratably with the holders
of the Class A Common Stock.

         Each unit of Series C Preferred Stock issued to a holder of our common
stock one vote, voting together with our common stock.

         In the event of any merger, share exchange or other transaction in
which shares of our common stock are exchanged, each unit of Series C Preferred
Stock will be entitled to receive the per share amount paid in respect of each
share of Class A Common Stock.

         The rights of holders of the Series C Preferred Stock to dividends,
liquidation and voting, and in the event of mergers and share exchanges, are
protected by customary anti-dilution provisions.

         Because of the nature of the Series C Preferred Stock's dividend,
liquidation and voting rights, the economic value of one unit of Series C
Preferred Stock that may be acquired upon the exercise of each right should
approximate the economic value of one share of Class A Common Stock.

         The rights may have certain anti-takeover effects. The rights will
cause substantial dilution to a person or group that attempts to acquire us on
terms not approved by a majority of our board of directors unless the offer is
conditioned on a substantial number of rights being acquired. However, the
rights should not interfere with any merger or other business combination
approved by our board of directors since the rights may be redeemed by us at
$0.001 per right at any time on or prior to the tenth day following the
announcement that someone has become an Acquiring Person. Thus, the rights are
intended to encourage persons who may seek to acquire control of us to initiate
such an acquisition through negotiations with our board of directors. However,
the effect of the rights may be to discourage a third party from making a
partial tender offer or otherwise attempting to obtain a substantial equity
position in the equity securities of, or seeking to obtain control of, us. To
the extent any potential acquirers are deterred by the rights, the rights may
have the effect of preserving incumbent management in office.

         The form of rights agreement between the Company and the rights agent
specifying the terms of the rights, which includes as Exhibit A the form of
rights certificate, is filed as Exhibit 4 to our Current Report on Form 8-K
filed with the SEC on December 3, 1999 and is incorporated herein by reference.
The foregoing description of the rights does not purport to be complete and is
qualified in its entirety by reference to such Exhibit.

Item 2.  Exhibits

         1.       Rights Agreement, dated December 2, 1999, between AmSurg Corp.
                  and SunTrust Bank, Atlanta, including the Form of Rights
                  Certificate (Exhibit A), the Form of Summary of Rights
                  (Exhibit B) and the Form of Articles of Amendment to the
                  Amended and Restated Charter of AmSurg Corp. (Exhibit C) is
                  incorporated herein by reference to Exhibit 4 to the Company's


                                       6
<PAGE>   7


                  Current Report on Form 8-K filed with the Securities and
                  Exchange Commission on December 3, 1999.


                                       7
<PAGE>   8



                                    SIGNATURE

         Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.

                                      AMSURG CORP.

                                      By: /s/ Claire M. Gulmi
                                          --------------------------------------
                                      Name: Claire M. Gulmi
                                      Title: Senior Vice President and Chief
                                               Financial Officer

Dated: December 3, 1999





                                       8
<PAGE>   9


                                  EXHIBIT INDEX

1.       Rights Agreement, dated December 2, 1999, between AmSurg Corp. and
         SunTrust Bank, Atlanta, including the Form of Rights Certificate
         (Exhibit A), the Form of Summary of Rights (Exhibit B) and Form of
         Articles of Amendment to the Amended and Restated Charter of AmSurg
         Corp. (Exhibit C) is incorporated herein by reference to Exhibit 4 to
         the Company's Current Report on Form 8-K filed with the Securities and
         Exchange Commission on December 3, 1999.








                                       9


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission